Dacarbazine
Links shared publicly online about this topic
Oncology Article | Melanoma Dacarbazine
mdlinx.com — “Ipilimumab plus dacarbazine for previously untreated metastatic melanoma” View full resource at mdlinx.com
Most Recently Shared on June 8, 2011 at 7:12 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma: New England Journal of Medicine http://bit.ly/kAq7aq #oncology
Dr. Hoos on the Ipilimumab Plus Dacarbazine Trial
onclive.com — “Dr. Axel Hoos medical lead at bristol-myers squibb on the Ipilimumab Plus Dacarbazine Combination Trial” View full resource at onclive.com
Most Recently Shared on July 29, 2011 at 8:52 pm By:
Dr. Axel Hoos medical lead @bristol_myers on the Ipilimumab Plus Dacarbazine Combination Trial http://t.co/1bewNdn #onclivetv
Addition of Ipilimumab to Dacarbazine Improves Survival in Metastatic Melanoma - ONA
oncologynurseadvisor.com — “Ipilimumab in combination with dacarbazine significantly improved overall survival (OS) in metastatic melanoma compared with dacarabazine alone, according to data presented at the American Society of Clinical Oncology’s 2011 Annual Meeting.” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 5, 2011 at 10:11 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Addition of Ipilimumab to Dacarbazine Improves Survival in Metastatic Melanoma http://goo.gl/fb/MMbg2
Addition of Ipilimumab to Dacarbazine Improves Survival in Metastatic Melanoma - MPR
empr.com — “Ipilimumab in combination with dacarbazine significantly improved overall survival (OS) in metastatic melanoma compared with dacarabazine alone, according to data presented at the American Society of Clinical Oncology’s 2011 Annual Meeting.” View full resource at empr.com
Most Recently Shared on June 5, 2011 at 9:59 pm By:
#asco2011 Addition of Ipilimumab to Dacarbazine Improves Survival in Metastatic Melanoma http://goo.gl/fb/PW8fN
ASCO: Ipilimumab Plus Dacarbazine Prolongs Metastatic Melanoma Survival : Skin & Allergy News
skinandallergynews.com — “Skin & Allergy News Digital Network is the online destination and multimedia properties of Skin & Allergy News, the independent news publication for the dermatology community. Our breaking news covers all areas of medical dermatology, dermatologic surgery, and aesthetic dermatology. We also provide the news by specialty interest: acne and rosacea, atopic dermatitis and eczema, cutaneous oncology, hair and nails, infectious diseases, pediatric dermatology, psoriasis and rheumatologic disorders, s” View full resource at skinandallergynews.com
Most Recently Shared on June 6, 2011 at 1:37 pm By:
Skin & Allergy News Health News
ASCO: Ipilimumab Plus Dacarbazine Prolongs Metastatic Melanoma Survival http://tinyurl.com/6h5577v
Second Phase 3 Study of YERVOY (ipilimumab) in Metastatic Melanoma Meets Primary Endpoint of Overall Survival - Drugs.com MedNews
drugs.com — “Study 024 Evaluated Newly-Diagnosed Patients Treated with YERVOY at Investigational Dose of 10mg kg in Combination with Dacarbazine vs. Dacarbazine Alone Forty-” View full resource at drugs.com
Most Recently Shared on June 6, 2011 at 12:13 pm By:
Drugs and Devices OW OW Health
Second Phase 3 Study of YERVOY (ipilimumab) in Metastatic Melanoma Meets Primary Endpoint of Overall Survi... http://bit.ly/jlNLPz #drug
Genta Announces Top-Line Results Of AGENDA Phase 3 Trial Of Genasense(R) In Patients With Advanced Melanoma
medicalnewstoday.com — “Genta Incorporated (OTCBB: GETA) announced top-line results from AGENDA, the Company's Phase 3 trial of Genasense® (oblimersen sodium) Injection in patients with advanced melanoma. AGENDA is a” View full resource at medicalnewstoday.com
Most Recently Shared on November 2, 2009 at 3:37 pm By:
MNT Clinical Trials Health News
Genta Announces Top-Line Results Of AGENDA Phase 3 Trial Of Genasense(R) In Patients With Advanced Melanoma: Ge.. http://bit.ly/3L0RgJ
Melanoma on #MDlinx
mdlinx.com — “Melanoma on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 3, 2010 at 4:25 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase 3 study of docosahexaenoic acid–paclitaxel versus dacarbazine in patients with metastatic malignant... http://bit.ly/c3AEGP #medicine
Endocrinology Article | Thyroid Neoplasms
mdlinx.com — “Treatment of Advanced Medullary Thyroid Carcinoma with a Combination of Cyclophosphamide, Vincristine, and Dacarbazine: a Single-Center Experience” View full resource at mdlinx.com
Most Recently Shared on July 11, 2011 at 5:25 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Treatment of Advanced Medullary Thyroid Carcinoma with a Combination of Cyclophosphamide, Vincristine, and... http://bit.ly/otbB9f #endo
Oncology Medical News about Lymphoma
mdlinx.com — “Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas” View full resource at mdlinx.com
Most Recently Shared on June 17, 2010 at 11:10 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, ... http://bit.ly/d4HmoQ #oncology
Oncology Article | melanoma
mdlinx.com — “Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumours” View full resource at mdlinx.com
Most Recently Shared on August 4, 2011 at 9:54 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with ... http://bit.ly/o5TOfl #oncology
Melanoma Oncofacts - 2010 Annual Oncology Meeting -- With Dr. Christy Russell, MD
oncologytube.com — “Melanoma Oncofacts - 2010 Annual Oncology Meeting -- With Dr. Christy Russell, MD: To see more OncoFacts go to http://www.oncofacts.com Melanoma There are only 2 US Food and Drug Administration (FDA)--approved agents for metastatic melanoma. Dacarbazine (DTIC) has a response ra...” View full resource at oncologytube.com
Most Recently Shared on May 4, 2011 at 4:27 pm By:
Melanoma Oncofacts - 2010 Annual Oncology Meeting – With Dr. Christy Russell, MD http://fb.me/Kyc4iuqV
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Editor
Editors of Oncology & Biotech News/Oncology Net Guide/OncNurse/Contemporary Oncology, on cancer news from pharma, trials, technology, & more.
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
Advertisement
